Conference Coverage

New insights emerge from pediatric chronic cutaneous lupus


 

AT THE SPD ANNUAL MEETING

References

"I love this study," commented SPD President Dr. Beth A. Drolet, professor of dermatology at the Medical College of Wisconsin, Milwaukee. "Your point that if transformation to SLE happens, it’s going to happen quickly – that’s enormously helpful to me clinically."

The study was funded by the SPD. Dr. Arkin reported having no financial conflicts.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Tool predicts lymphoma, death in primary Sjögren’s syndrome patients
MDedge Rheumatology
Eurofever Project takes aim at rare autoinflammatory disorders
MDedge Rheumatology
Live births seen in half of pregnancies exposed to belimumab
MDedge Rheumatology
VIDEO: Slow tapering worked best for stopping SLE immunosuppression
MDedge Rheumatology
SLE patients in remission safely stop immunotherapy
MDedge Rheumatology
Increased risk of heart attack confirmed in Sjögren’s syndrome patients
MDedge Rheumatology
Real-world use supports belimumab clinical trial data
MDedge Rheumatology
Trial of sirukumab for lupus nephritis falls flat
MDedge Rheumatology
Deaths mar atacicept trial for lupus, but research continues
MDedge Rheumatology
Rituximab yielded long-term benefit in lupus nephritis
MDedge Rheumatology